Dr. Tina Bhutani-Jacques, MD

Dr. Bhutani-Jacques practices at Synergy Dermatology in San Francisco, California.

Dr. Bhutani-Jacques' NPI, 1144483124, was assigned on July 9, 2008. Dr. Bhutani-Jacques graduated from Keck School of Medicine of USC in 2008. Dr. Bhutani-Jacques holds California license A108915.

Dr. Bhutani-Jacques' primary practice is Synergy Dermatology, at 595 Buckingham Way Suite 220 Suite 220, San Francisco, CA 94132-1910. The practice phone is (415) 333-0348.

Dr. Bhutani-Jacques' primary practice is Synergy Dermatology in San Francisco, California. The medical group on file is Synergy Dermatology. Dmand AI also links Dr. Bhutani-Jacques to 2 more medical groups and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bhutani-Jacques practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Bhutani-Jacques' primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Bhutani-Jacques is board certified in dermatology by the American Board of Dermatology. Dr. Bhutani-Jacques is licensed in California.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, contact dermatitis, corns and calluses, itchy rashes, psoriasis and rash among the conditions Dr. Bhutani-Jacques treats.

CMS data shows 3,626 Medicare services from Dr. Bhutani-Jacques across 14 procedure codes in 2024, for 679 Medicare patients. Medicare paid $261,706 for them. Every service was in an office.

CMS counts 679 Medicare patients who saw Dr. Bhutani-Jacques in 2024. The largest group is 65 to 74, with 279 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 20% are also on Medicaid. Their average risk score is 1.10, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bhutani-Jacques' median patient age at 62, with 46% women.

In 2024, Dr. Bhutani-Jacques wrote 1,521 Medicare Part D claims for 416 patients. 78% of them were for generic drugs. CMS names the drug for 1,346 of them, across 33 drugs with 11 or more claims each, at $2,166,851 in total drug cost. In 2023, CMS named 1,084 claims across 31 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Bhutani-Jacques for performance year 2024, reported individually. Dr. Bhutani-Jacques accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 1,080 procedures of removal of skin lesions by Dr. Bhutani-Jacques, more than 94% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Bhutani-Jacques in 2024. Dr. Bhutani-Jacques' most frequent co-authors are Lianne Simone Gensler, MD and Uma Mahadevan, MD.

Dmand AI links Dr. Bhutani-Jacques to 4 clinical trials, 3 of them phase 4 studies. Conditions studied include Psoriasis and Skin Diseases, Papulosquamous. University of California, San Francisco sponsors the most, 3.

CMS Open Payments shows 1,315 general payments to Dr. Bhutani-Jacques from 29 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 50% of the total. Janssen Pharmaceuticals, Inc paid the most, $194,954. It also lists 9 research payments totaling $34,259 from 2016 to 2022.

Dmand AI lists 7 awards for Dr. Bhutani-Jacques, most recently National Psoriasis Foundation Medical Dermatology Research Grant Recipient in 2012.

Dr. Bhutani-Jacques graduated from Keck School of Medicine of USC in 2008.

Dr. Bhutani-Jacques is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.